Financial Inside information: Bioretec is revising its financial targets, deems that the current financial targets will not be met and withdraws its financial targets byTim AllenOctober 27, 2025
Financial Hospitals Regulatory Top Stories Bioretec’s RemeOs™ Screw LAG Solid Receives CMS Transitional Pass-Through Payment in the US byNoah SimmonsOctober 1, 2025
Biologics Extremities Spine Bioretec Appoints Jordy Winters as Vice President of OUS Sales to Accelerate International Growth byTim AllenSeptember 2, 2025
Extremities Top Stories Bioretec Appoints Sarah van Hellenberg Hubar-Fisher as Chief Executive Officer byJosh SandbergAugust 27, 2025
Extremities Spine Inside information: Sarah van Hellenberg Hubar-Fisher appointed interim CEO of Bioretec byTim AllenMay 15, 2025
Financial Bioretec Ltd’s Board of Directors has decided on a new option program for the CEO byTim AllenMarch 21, 2025
Extremities Regulatory Top Stories CE Mark Approval for RemeOs™ Trauma Screw Product Group, featuring four product lines with over 200 individual products, drives global expansion for Bioretec byBree MillerFebruary 14, 2025
Extremities Regulatory Inside information: Bioretec Ltd. receives CE mark approval for RemeOs™ Trauma Screw product portfolio, allowing market launch in Europe byTim AllenJanuary 31, 2025
Extremities The commercialization of Bioretec’s RemeOs™ Trauma Screw in the U.S. proceeds with the signing of new logistics agreement byJosh SandbergNovember 20, 2024
